PRRT2 and thoracic cancer: As expected, PKC activity in cultured thoracic cancer cells, as indicated by p-adducin levels, was completely abrogated by either STP or UCN-01, with STP mediating a very rapid onset of PKC inhibition and UCN-01 mediating a slower onset of PKC inhibition.